Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,330 | 31,846 | 62,788 | 43,101 | 26,285 |
| Marketable Securities | 86,293 | 95,948 | 79,198 | 86,139 | 99,718 |
| Receivables | 2,409 | 1,608 | 1,767 | 2,139 | 1,776 |
| TOTAL | $127,316 | $132,777 | $148,220 | $135,872 | $132,027 |
| Non-Current Assets | |||||
| PPE Net | 3,309 | 3,556 | 4,059 | 4,414 | 4,674 |
| Investments And Advances | 0 | 2,964 | 6,527 | 8,677 | 6,284 |
| Other Non-Current Assets | 1,082 | 1,144 | 1,237 | 1,327 | 1,416 |
| TOTAL | $4,391 | $7,664 | $11,823 | $14,418 | $12,374 |
| Total Assets | $131,707 | $140,441 | $160,043 | $150,290 | $144,401 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,564 | 7,544 | 11,108 | 8,247 | 10,271 |
| TOTAL | $15,618 | $18,923 | $22,595 | $20,296 | $22,487 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,571 | 10,911 | 11,034 | 11,547 | 11,791 |
| Other Non-Current Liabilities | 15,860 | 14,628 | 14,994 | 15,357 | 15,896 |
| TOTAL | $18,723 | $14,628 | $14,994 | $15,357 | $15,896 |
| Total Liabilities | $34,341 | $33,551 | $37,589 | $35,653 | $38,383 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 191,480 | 189,492 | 188,782 | 188,717 | 179,492 |
| Common Shares | 1,410,025 | 1,407,595 | 1,403,334 | 1,377,315 | 1,349,821 |
| Retained earnings | -1,346,572 | -1,334,040 | -1,314,323 | -1,294,527 | -1,276,652 |
| Other shareholders' equity | -48,135 | -48,090 | -48,308 | -48,371 | -48,421 |
| TOTAL | $97,366 | $106,890 | $122,454 | $114,637 | $106,018 |
| Total Liabilities And Equity | $131,707 | $140,441 | $160,043 | $150,290 | $144,401 |